ProstaLund CoreTherm BPH Device Arrives In U.S., Distributed Through ACMI

ProstaLund will immediately fill $2.3 mil. in back-orders for its CoreTherm microwave transurethral benign prostatic hyperplasia (BPH) treatment device, approved via PMA in December